Showing 1 - 20 results of 305 for search '(( 5 min decrease ) OR ( 10 ((greater decrease) OR (((a decrease) OR (_ decrease)))) ))~', query time: 0.90s Refine Results
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12

    Table_1_Effects of Early Changes in Blood Pressure During Intravenous Thrombolysis on the Prognosis of Acute Ischemic Stroke Patients.docx by Zhong-Xiu Wang (9729359)

    Published 2020
    “…Patients with a lower baseline National Institute of Health Stroke Scale (NIHSS) score (8.25 ± 5.57 vs. 13.51 ± 7.42, P < 0.001), a higher Alberta Stroke Program Early CT Score (ASPECTS; 8.65 ± 1.82 vs. 8.13 ± 2.00, P = 0.005), decreased BP during thrombolysis (69.4% vs. 59.8%, P = 0.037), and steady BP (SD < 10 mmHg) were more likely to have a favorable outcome (73.9% vs. 60.6%, P = 0.019). …”
  13. 13

    Demographic data of female participants (n = 30). by Vanessa Wellauer (18408477)

    Published 2025
    “…Participants completed a standardised exercise protocol (5 x 20 drop-jumps), followed by a 10min recovery intervention (CWI, HWI, or CON) immediately and 120 min post-exercise. …”
  14. 14

    Raw data used for statistical analysis. by Vanessa Wellauer (18408477)

    Published 2025
    “…Participants completed a standardised exercise protocol (5 x 20 drop-jumps), followed by a 10min recovery intervention (CWI, HWI, or CON) immediately and 120 min post-exercise. …”
  15. 15

    CONSORT flowchart of participants. by Vanessa Wellauer (18408477)

    Published 2025
    “…Participants completed a standardised exercise protocol (5 x 20 drop-jumps), followed by a 10min recovery intervention (CWI, HWI, or CON) immediately and 120 min post-exercise. …”
  16. 16

    Table_1_Decreased circulating dipeptidyl peptidase-4 activity after short-term intensive insulin therapy predicts clinical outcomes in patients with newly diagnosed type 2 diabetes... by Jie Chen (5892)

    Published 2024
    “…After three months post-SIIT, DPP-4 activity remained stable in the remission group (39.63 ± 8.53 nmol/L) but increased in the non-remission group (42.34 ± 6.64 nmol/L). This resulted in a more pronounced decrease in DPP-4 activity from baseline in the remission group (-3.39 ± 8.90 vs. -1.10 ± 8.95, P = 0.035). …”
  17. 17
  18. 18
  19. 19
  20. 20